Galmed Pharmaceuticals Ltd. buy BTIG Research
Start price
29.05.24
/
50%
€0.33
Target price
29.05.25
€66.36
Performance (%)
1827.71%
Price
19.09.24
€6.40
Summary
This prediction is currently active. The BUY prediction by BTIG_Research for Galmed Pharmaceuticals Ltd. has seen massive gains of 1827.71%. This prediction currently runs until 29.05.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | - | - |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by BTIG_Research for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $63.00 to $72.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by BTIG_Research for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.24
28.08.24
28.08.24
€69.28
28.08.25
28.08.25
2589.08%
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.27
16.07.24
16.07.24
€68.81
16.07.25
16.07.25
-15.56%
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.36
08.05.24
08.05.24
€58.61
08.05.25
08.05.25
1667.96%
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.30
18.03.24
18.03.24
€55.09
18.03.25
18.03.25
2062.16%
19.09.24
19.09.24